Neuropathological epidemiology of cerebral aging: a study of two genetic polymorphisms
- PMID: 11182472
- DOI: 10.1016/s0197-4580(00)00227-x
Neuropathological epidemiology of cerebral aging: a study of two genetic polymorphisms
Abstract
We studied whether ApoE and -219 GT (ApoE promoter) polymorphism modulates neurofibrillary tangle (NFT) and senile plaque (SP) development in aging among 190 non-institutionalized individuals (mean age 79.5 years). Analysis revealed that the mean Braak stage was higher in epsilon4 allele carriers. Once individuals with Braak stage V were excluded (n = 5), relationships between NFT and the two genotypes studied were weak, whereas in epsilon4 allele carriers, the risk of SP was multiplied by 4 to 7 in four areas (CA1, subiculum, isocortex and entorhinal cortex). This association was more pronounced in subjects under 80 years and was also observed when analysis was restricted to Braak stages 0, I and II. Epsilon 2 allele carriers appeared to have fewer lesions but, due to limited numbers, this trend was not significant. In two regions (CA1, subiculum), the number of SP increased significantly for individuals who were homozygous for the T allele of -219 GT. However the association was no longer significant when controlling for ApoE epsilon4. It should be noted that the brain of elderly subjects carrying one epsilon4 allele may not undergo senile changes.
Similar articles
-
Association of estrogen receptor alpha gene polymorphisms with neurofibrillary tangles.Dement Geriatr Cogn Disord. 2004;18(2):145-50. doi: 10.1159/000079194. Epub 2004 Jun 18. Dement Geriatr Cogn Disord. 2004. PMID: 15211069
-
Clinicopathologic studies in cognitively healthy aging and Alzheimer's disease: relation of histologic markers to dementia severity, age, sex, and apolipoprotein E genotype.Arch Neurol. 1998 Mar;55(3):326-35. doi: 10.1001/archneur.55.3.326. Arch Neurol. 1998. PMID: 9520006
-
Impact of APOE genotype on neuropathologic and neurochemical markers of Alzheimer disease.Neurology. 2004 Jun 8;62(11):1977-83. doi: 10.1212/01.wnl.0000128091.92139.0f. Neurology. 2004. PMID: 15184600
-
APOE, vascular pathology, and the AD brain.Neurology. 2005 Jul 26;65(2):259-65. doi: 10.1212/01.wnl.0000168863.49053.4d. Neurology. 2005. PMID: 16043796
-
Apolipoprotein E in neurology.Curr Opin Neurol. 1996 Aug;9(4):265-70. doi: 10.1097/00019052-199608000-00004. Curr Opin Neurol. 1996. PMID: 8858183 Review.
Cited by
-
Increased expression of BIN1 mediates Alzheimer genetic risk by modulating tau pathology.Mol Psychiatry. 2013 Nov;18(11):1225-34. doi: 10.1038/mp.2013.1. Epub 2013 Feb 12. Mol Psychiatry. 2013. PMID: 23399914 Free PMC article.
-
The allelic modulation of apolipoprotein E expression by oestrogen: potential relevance for Alzheimer's disease.J Med Genet. 2004 Feb;41(2):104-12. doi: 10.1136/jmg.2003.005033. J Med Genet. 2004. PMID: 14757857 Free PMC article.
-
Transcriptomic and genetic studies identify IL-33 as a candidate gene for Alzheimer's disease.Mol Psychiatry. 2009 Nov;14(11):1004-16. doi: 10.1038/mp.2009.10. Epub 2009 Feb 10. Mol Psychiatry. 2009. PMID: 19204726 Free PMC article.
-
Validating a Genomic Convergence and Network Analysis Approach Using Association Analysis of Identified Candidate Genes in Alzheimer's Disease.Front Genet. 2021 Dec 9;12:722221. doi: 10.3389/fgene.2021.722221. eCollection 2021. Front Genet. 2021. PMID: 34956307 Free PMC article.
-
Is there a significant interaction effect between apolipoprotein E rs405509 T/T and ε4 genotypes on cognitive impairment and gray matter volume?Eur J Neurol. 2016 Sep;23(9):1415-25. doi: 10.1111/ene.13052. Epub 2016 Jun 4. Eur J Neurol. 2016. PMID: 27259692 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous